Artiva Biotherapeutics, Inc.
ARTV- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817241
In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Artiva Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +49 vs. Q2 2024
- Shares held
- 20.7M
- +20.7M vs. Q2 2024
- Total value
- $319.4M
- +$319.4M vs. Q2 2024
- New holders
- 49
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $391.6M |
| Q1 2026 | 40 | $108.4M |
| Q4 2025 | 34 | $72.7M |
| Q3 2025 | 40 | $52.1M |
| Q2 2025 | 48 | $27.9M |
| Q1 2025 | 53 | $62.8M |
| Q4 2024 | 57 | $213.2M |
| Q3 2024 | 49 | $319.4M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Artiva Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sterling Capital Management LLC | 31 | $479 | 0.00% | +31 | New |
| FMR LLC | 160 | $2.47K | 0.00% | +160 | New |
| Amalgamated Bank | 480 | $7.00K | 0.00% | +480 | New |
| Tower Research Capital LLC (TRC) | 720 | $11.1K | 0.00% | +720 | New |
| California State Teachers Retirement System | 1,041 | $16.1K | 0.00% | +1,041 | New |
| Mark Sheptoff Financial Planning, LLC | 1,300 | $20.1K | 0.01% | +1,300 | New |
| Legal & General Group Plc | 1,393 | $21.5K | 0.00% | +1,393 | New |
| Ameritas Investment Partners, Inc. | 1,424 | $22.0K | 0.00% | +1,424 | New |
| Royal Bank of Canada | 2,061 | $32.0K | 0.00% | +2,061 | New |
| STRS Ohio | 2,600 | $40.2K | 0.00% | +2,600 | New |
| BNP Paribas Arbitrage, SA | 2,728 | $42.1K | 0.00% | +2,728 | New |
| New York State Common Retirement Fund | 2,937 | $45.4K | 0.00% | +2,937 | New |
| Wells Fargo & Company | 5,255 | $81.2K | 0.00% | +5,255 | New |
| UBS Group AG | 6,618 | $102.2K | 0.00% | +6,618 | New |
| Corebridge Financial, Inc. | 7,515 | $116.1K | 0.00% | +7,515 | New |
| Mirae Asset Global ETFs Holdings Ltd. | 7,659 | $118.3K | 0.00% | +7,659 | New |
| MetLife Investment Management | 8,733 | $134.9K | 0.00% | +8,733 | New |
| Citigroup Inc | 10,181 | $157.3K | 0.00% | +10,181 | New |
| JPMorgan Chase & Co | 10,726 | $165.7K | 0.00% | +10,726 | New |
| Rhumbline Advisers | 14,829 | $229.1K | 0.00% | +14,829 | New |
| Bank of America Corp | 17,818 | $275.3K | 0.00% | +17,818 | New |
| Nuveen Asset Management, LLC | 18,611 | $287.5K | 0.00% | +18,611 | New |
| Barclays PLC | 19,616 | $303.1K | 0.00% | +19,616 | New |
| Goldman Sachs Group Inc | 29,547 | $456.5K | 0.00% | +29,547 | New |
| Norges Bank | 30,000 | $463.5K | 0.00% | +30,000 | New |
| Bank of New York Mellon Corp | 31,209 | $482.2K | 0.00% | +31,209 | New |
| Morgan Stanley | 39,953 | $617.3K | 0.00% | +39,953 | New |
| Charles Schwab Investment Management Inc | 40,293 | $622.5K | 0.00% | +40,293 | New |
| EcoR1 Capital, LLC | 41,453 | $640.4K | 0.02% | +41,453 | New |
| Acuta Capital Partners, LLC | 44,000 | $679.8K | 0.55% | +44,000 | New |
| State Street Corp | 86,559 | $1.34M | 0.00% | +86,559 | New |
| Citadel Advisors LLC | 103,635 | $1.52M | 0.00% | +103,635 | New |
| Alyeska Investment Group, L.P. | 100,000 | $1.54M | 0.01% | +100,000 | New |
| Cormorant Asset Management, LP | 103,633 | $1.60M | 0.08% | +103,633 | New |
| Northern Trust Corp | 112,777 | $1.74M | 0.00% | +112,777 | New |
| Logos Global Management LP | 145,089 | $2.13M | 0.24% | +145,089 | New |
| RTW Investments, LP | 148,844 | $2.30M | 0.03% | +148,844 | New |
| Wellington Management Group LLP | 194,108 | $2.91M | 0.00% | +194,108 | New |
| Woodline Partners LP | 283,124 | $4.37M | 0.04% | +283,124 | New |
| Samsara BioCapital, LLC | 291,666 | $4.51M | 0.87% | +291,666 | New |
| Geode Capital Management, LLC | 308,930 | $4.77M | 0.00% | +308,930 | New |
| Franklin Resources Inc | 520,301 | $7.44M | 0.00% | +520,301 | New |
| BlackRock, Inc. | 837,613 | $12.9M | 0.00% | +837,613 | New |
| Vanguard Group Inc | 841,005 | $13.0M | 0.00% | +841,005 | New |
| Capital World Investors | 915,386 | $14.1M | 0.00% | +915,386 | New |
| venBio Partners LLC | 1,519,971 | $23.5M | 12.08% | +1,519,971 | New |
| VR Adviser, LLC | 1,609,569 | $24.9M | 1.30% | +1,609,569 | New |
| 5AM Venture Management, LLC | 2,353,304 | $36.4M | 7.51% | +2,353,304 | New |
| Ra Capital Management, L.P. | 9,853,302 | $152.2M | 1.76% | +9,853,302 | New |